Minor Lloyd 4

What Happened Minor Lloyd, a director of Caris Life Sciences (CAI), was granted 2,492 shares on February 26, 2026. The shares were issued at an imputed price of $20.06 per share, for a total value of about $49,990. This was an award issued in lieu of cash compensation (not an open-market purchase or sale).

Key Details

• Transaction date and price: 2/26/2026, 2,492 shares at $20.06 each (total ≈ $49,990).
• Transaction code: A (award/grant/acquisition).
• Shares owned after transaction: Not disclosed on the Form 4 filing.
• Footnote: Shares were issued in lieu of 2025 board retainer fees; the number of shares was calculated by dividing the cash retainer by the 10-trading-day VWAP through and including Feb 25, 2026.
• Filing timeliness: Form 4 filed 2026-03-02 (within the two-business-day reporting window — timely).

Context This was a compensation-related grant (board retainer paid in stock), which increases the director’s holdings but is a routine form of director pay rather than a market purchase that necessarily signals a change in sentiment. The issuance method (conversion of cash retainer using a 10-day VWAP) is a common approach to determining share count for stock-in-lieu programs.